Abstract
Cancer of the penis is a rare malignancy with incidence rates of 0.3 to 8 per 100,000. High-incidence areas are found in South America, the highest being Brazil (8/100,000). It has a low incidence in countries where circumcision at birth or at a very young age is practiced (e.g. Israel, Middle East) (1,2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol 2004;5(4):240–247.
Stancik I, Holtl W. Penile cancer: review of the recent literature. Curr Opin Urol 2003;13(6):467–472.
Dillner J, vonKrogh G, Horenblas S, Meijer CJ. Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 2000;205:189–193.
Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1):12–19.
Ferreux E, Lont AP, Horenblas S, et al. Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 2003;201(1): 109–118.
Bezerra AL, Lopes A, Santiago GH, et al. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer 2001;91(12):2315–2321.
Munger K. The role of human papillomaviruses in human cancers. Front Biosci 2002;7:d641–d649.
Harish K, Ravi R. The role of tobacco in penile carcinoma. Br J Urol 1995;75: 375–377.
Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control 2001;12:267–277.
vonKrogh G, Horenblas S. Diagnosis and clinical presentation of premalignant lesions of the penis. Scand J Urol Nephrol Suppl 2000;205:201–214.
Sanchez-Ortiz RF, Pettaway CA. The role of lymphadenectomy in penile cancer. Urol Oncol 2004;22(3):236–244.
Liegl B, Regauer S. Penile clear cell carcinoma: a report of 5 cases of a distinct entity. Am J Surg Pathol 2004;28(11):1513–1517.
Horenblas S, vanTinteren H, Delemarre JF, et al. Squamous cell carcinoma of the penis. II. Treatment of the primary tumor. J Urol 1992;147(6):1533–1538.
Horenblas S, vanTinteren H, Delemarre JF, et al. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 1993;149(3):492–497.
Ornellas AA, Seixas AL, Marota A, et al. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 1994;151: 1244–1249.
Lopes A, Hidalgo GS, Kowalski LP, et al. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996;156(5):1637–1642.
Kroon BK, Horenblas S, Deurloo EE, Nieweg OE, Teertstra HJ. Ultrasonographyguided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int 2005;95:517–521.
Singh I, Khaitan A. Current trends in the management of carcinoma penis—a review. Int Urol Nephrol 2003;35(2):215–225.
Pizzocaro G, Piva L, Bandieramonte G, Tana S. Up-to-date management of carcinoma of the penis. Eur Urol 1997;32(1):5–15.
Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: diagnosis of lymph node metastasis. BJU Int 2001;88(5):467–472.
Horenblas S, vanTinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 1994;151(5):1239–1243.
Lont AP, Horenblas S, Tanis PJ, et al. Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol 2003;170(3):783–786.
Scardino E, Villa G, Bonomo G, et al. Magnetic resonance imaging combined with artificial erection for local staging of penile cancer. Urology 2004;63(6): 1158–1162.
Kroon BK, Horenblas S, Estourgie SH, et al. How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol 2004;171 (6 Pt 1): 2191–2194.
Tabatabaei S, Harisinghani M, McDougal WS. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol 2005;174(3):923–927.
Minhas S, Kayes O, Hegarty P, et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int 2005;96(7): 1040–1043.
Brown CT, Minhas S, Ralph DJ. Conservative surgery for penile cancer: subtotal glans excision without grafting. BJU Int 2005;96(6):911–912.
Sagerman RH, Yu WS, Chung CT, Puranik A. External-beam irradiation of carcinoma of the penis. Radiology 1984;152(1):183–185.
Crook JM, Jezioranski J, Grimard L, Esche B, Pond G. Penile brachytherapy: results for 49 patients. Int J Radiat Oncol Biol Phys 2005;62(2):460–467.
Solsona E, Iborra I, Rubio J, et al. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 2001;165(5):1506–1509.
McDougal WS. Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion. J Urol 1995;154(4):1364–1366.
Horenblas S, Jansen L, Meinhardt W, et al. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol 2000; 163(1):100–104.
Kroon BK, Horenblas S, Meinhardt W, et al. Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol 2005;47(5):601–606.
Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int 2001;88(5):473–483.
Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol 2003;170 (2 pt 1):359–365.
Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after long-term followup. J Urol 2003;169(6):2118–2121.
d’Ancona CA, Botega NJ, De Moraes C, Lavoura NS, Jr., Santos JK, Rodrigues Netto N, Jr. Quality of life after partial penectomy for penile carcinoma. Urology 1997;50: 593–596.
Opjordsmoen S, Fossa SD. Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol 1994;74(5):652–657.
Lowe FC. Squamous-cell carcinoma of the scrotum. Urol Clin North Am 1992; 19(2):397–405.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Horenblas, S., Kroon, B.K. (2008). Cancer of the Penis and Scrotum. In: Nargund, V.H., Raghavan, D., Sandler, H.M. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-1-84628-738-1_33
Download citation
DOI: https://doi.org/10.1007/978-1-84628-738-1_33
Publisher Name: Springer, London
Print ISBN: 978-1-84628-387-1
Online ISBN: 978-1-84628-738-1
eBook Packages: MedicineMedicine (R0)